Next, we will broadly outline three tumor immune-escape strategies involving LFA-1: altered LFA-1-mediated migration and infiltration of leukocytes into the tumor microenvironment, disrupted LFA-1 functionality in leukocytes within the tumor microenvironment, and LFA-1-mediated tumor invasiveness. The gene discussed is ITGAL; the disease is neoplasm.